BBIO SG&A Expense Growth

Bridgebio Pharma Inc · SG&A Expense Growth

BBIO logo

BBIO SG&A Expense Growth

Latest reported92.14%
BBIO FY SG&A Growth (YoY) (0.00% → 92.14%)
High-resolution chart · PNG

BBIO sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
92.1358%
91.866%
5.1687%
-25.5039%
31.9362%
54.4031%
116.4705%
227.6725%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.